Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Minerva Neurosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Minerva Neurosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kaul Inderjit | Director | – | Aug 3, 2026 | 5 |
| Van Heek G Jan | Director | – | Jun 5, 2026 | 2 |
| Hasler Hans Peter | Director | – | Jun 5, 2026 | 2 |
| Ahlholm Frederick W | SVP, CFO and Secretary | 17,518 | Jun 5, 2026 | 2 |
| Luthringer Remy | CEO | 68,994 | Jun 5, 2026 | 2 |
| Laghrissi-Thode Fouzia | Director | – | Jun 5, 2026 | 2 |
| Kupfer David | Director | 163,553 | Jun 5, 2026 | 2 |
| O'Connor James Joseph | Chief Business Officer and GC | – | Apr 22, 2026 | 1 |
| Race Geoff | President | 51,324 | Dec 23, 2025 | 1 |
| Hilleman Jeryl L | Director | – | Sep 29, 2023 | 0 |
| Barclays PLC | 10% Owner | – | Aug 16, 2022 | 0 |
| Doyle William F | Director | – | Jun 28, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2023 (view filing) | May 1-2 | 1 day | Luthringer RemyCEO | SSale | −27.4K | $3.84 | −$105.1K | −28.4%69.0K after | 2 lots |
| May 2, 2023 (view filing) | May 1 | 1 day | Race GeoffPresident | SSale | −22.1K | $3.85 | −$85.0K | −30.1%51.3K after | |
| May 2, 2023 (view filing) | May 1 | 1 day | Ahlholm Frederick WSVP, CFO and Secretary | SSale | −3.58K | $4.48 | −$16.0K | −17.0%17.5K after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Kupfer DavidDirector | SSale | −55.6K | $0.88 | −$49.0K | −25.4%163.6K after |